title: Vision Loss With Pachymeningeal Enhancement on Magnetic Resonance Imaging.
authors.affiliation: University of Missouri, Kansas City.
authors.forename: Matthew
authors.initials: M
authors.lastname: Cossack
authors.affiliation: University of Missouri, Kansas City.
authors.forename: Sai
authors.initials: S
authors.lastname: Vanam
authors.affiliation: University of Missouri, Kansas City.
authors.forename: Billi
authors.initials: B
authors.lastname: Wallace
mesh_terms: D001766:Blindness / Q000175:diagnosis*; D002560:Cerebrovascular Circulation; D004338:Drug Combinations; D004388:Dura Mater / Q000098:blood supply / Q000000981:diagnostic imaging / Q000473:pathology*; D005938:Glucocorticoids / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D008578:Meninges / Q000098:blood supply / Q000000981:diagnostic imaging / Q000473:pathology*; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011241:Prednisone; D008775:Methylprednisolone; D008727:Methotrexate